InsiderDB
Sign inStart free trial

AbbVie (ABBV)

Healthcare · Drug Manufacturers - General

32 members of Congress have disclosed 112 trades in AbbVie (ABBV) since 2014: 53 buys and 59 sales. The most recent was disclosed on Nov 5, 2026. 1 trade was made by members of a committee that oversees AbbVie's industry.

Trades disclosed
112
Members trading
32
Buys / sells
53 / 59
Reported value
$1.1M–$3.8M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow ABBV

What else is happening at ABBV

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. ABBVFinancial report·SEC EDGAR

    ABBV: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 3, 2026, 1:43 PM ESTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. ABBVCompany announcement·SEC EDGAR

    ABBV: Leadership change

    Filed 8-K for an event or period dated 2026-10-28. Leadership change.

    Public: Nov 2, 2026, 4:05 PM ESTEvent / period: Oct 28, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. ABBVCompany announcement·SEC EDGAR

    ABBV: Financial results

    Filed 8-K for an event or period dated 2026-10-30. Financial results.

    Public: Oct 30, 2026, 7:51 AM EDTEvent / period: Oct 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. ABBVLobbying report·Lobbying disclosures

    ABBV: third_quarter 2026 lobbying report

    Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Policies as they relate to PBMs Issues related to the budget and appropriations process Issues related to the treatment of vitiligo Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act Issues related to the budget and appropriations process

    Public: Oct 20, 2026, 10:55 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. ABBVLobbying report·Lobbying disclosures

    ABBV: third_quarter 2026 lobbying report

    Issues related to the 340B drug discount program. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals.

    Public: Oct 20, 2026, 5:36 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees AbbVie's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded ABBV

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.